Showing results (151-160 of 174) with videos related to
Sort By:
Pageof 18
Microbial Pathogenesis|June 21, 2017
Antigenicity of phage clones and their synthetic peptides for the serodiagnosis of canine and human visceral leishmaniasisLourena E Costa, Beatriz C S Salles, Thaís T O Santos, et al.Nature Metabolism|November 13, 2023
Inhibition of the proline metabolism rate-limiting enzyme P5CS allows proliferation of glutamine-restricted cancer cellsSamantha J Linder, Tiziano Bernasocchi, Bárbara Martínez-Pastor, et al.Cellular Immunology|June 13, 2017
An ELISA immunoassay employing a conserved Leishmania hypothetical protein for the serodiagnosis of visceral and tegumentary leishmaniasis in dogs and humansAna Maria R S Carvalho, Lourena E Costa, Beatriz C S Salles, et al.Journal of Psychiatric Research|January 1, 2023
Maternal expression of miR-let-7d-3p and miR-451a during gestation influences the neuropsychomotor development of 90 days old babies: "Pregnancy care, healthy baby" studyFernanda Nedel, Camila P Ferrúa, Cainá C do Amaral, et al.Diagnostic Microbiology and Infectious Disease|June 4, 2019
Diagnostic evaluation of the amastin protein from Leishmania infantum in canine and human visceral leishmaniasis and immunogenicity in human cells derived from patients and healthy controlsDanniele L Vale, Daniel S Dias, Amanda S Machado, et al.Immunobiology|September 30, 2018
Potential application of small myristoylated protein-3 evaluated as recombinant antigen and a synthetic peptide containing its linear B-cell epitope for the serodiagnosis of canine visceral and human tegumentary leishmaniasisBeatriz C S Salles, Daniel S Dias, Bethina T Steiner, et al.Nature Metabolism|February 23, 2021
A unique subset of glycolytic tumour-propagating cells drives squamous cell carcinomaJee-Eun Choi, Carlos Sebastian, Christina M Ferrer, et al.Diagnostic Microbiology and Infectious Disease|June 27, 2018
A conserved Leishmania hypothetical protein evaluated for the serodiagnosis of canine and human visceral and tegumentary leishmaniasis, as well as a serological marker for the posttreatment patient follow-upPatrícia A F Ribeiro, Daniel S Dias, Daniela P Lage, et al.Nature Cell Biology|June 16, 2025
ZNF280A links DNA double-strand break repair to human 22q11.2 distal deletion syndromeThomas L Clarke, Hyo Min Cho, Ilaria Ceppi, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 20, 2016
Effects of Organizational Characteristics on Outcomes and Resource Use in Patients With Cancer Admitted to Intensive Care UnitsMarcio Soares, Fernando A Bozza, Luciano C P Azevedo, et al.Pageof 18